OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery and delivery strategies for engineered live biotherapeutic products
Mairead K. Heavey, Deniz Durmusoglu, Nathan Crook, et al.
Trends in biotechnology (2021) Vol. 40, Iss. 3, pp. 354-369
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
Fen Zhang, Raphaela Iris Lau, Qin Liu, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 5, pp. 323-337
Open Access | Times Cited: 188

Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis
Mairead K. Heavey, Anthony Hazelton, Yuyan Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 25

Intestinal Delivery of Probiotics: Materials, Strategies, and Applications
Chengcheng Li, Zi‐Xi Wang, Huining Xiao, et al.
Advanced Materials (2024) Vol. 36, Iss. 32
Closed Access | Times Cited: 24

Microfluidic-based multifunctional microspheres for enhanced oral co-delivery of probiotics and postbiotics
Xinyuan Yang, Weimin Nie, Chong Wang, et al.
Biomaterials (2024) Vol. 308, pp. 122564-122564
Closed Access | Times Cited: 21

Carotenoids and Their Health Benefits as Derived via Their Interactions with Gut Microbiota
Abdulkerim Eroglu, Ibrahim S. Al’Abri, Rachel E. Kopec, et al.
Advances in Nutrition (2022) Vol. 14, Iss. 2, pp. 238-255
Open Access | Times Cited: 59

Genetically engineered bacterium: Principles, practices, and prospects
Yiting Liu, Jing Feng, Hangcheng Pan, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 51

Triggerable Prodrug Nanocoating Enables On-Demand Activation of Microbial and Small-Molecular Therapeutics for Combination Treatment
Xiao Kuang, Ying Liu, Huilong Luo, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 49, pp. 26932-26946
Closed Access | Times Cited: 27

Good girl goes bad: Understanding how gut commensals cause disease
Priyankar Dey
Microbial Pathogenesis (2024) Vol. 190, pp. 106617-106617
Closed Access | Times Cited: 9

A decade of advances in human gut microbiome-derived biotherapeutics
Alena L. Pribyl, Philip Hugenholtz, Matthew A. Cooper
Nature Microbiology (2025)
Closed Access | Times Cited: 1

Armored probiotics for oral delivery
Xinyuan Yang, Chong Wang, Qiao Wang, et al.
Smart Medicine (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 22

A Customized Biohybrid Presenting Cascade Responses to Tumor Microenvironment
Feiyu Li, Peipei Zhu, Bingzhu Zheng, et al.
Advanced Materials (2024) Vol. 36, Iss. 30
Closed Access | Times Cited: 8

Engineered bacterial therapeutics with material solutions
Sourik Dey, Shrikrishnan Sankaran
Trends in biotechnology (2024)
Open Access | Times Cited: 5

Genetically engineered bacteria: a new frontier in targeted drug delivery
Saba Fooladi, Navid Rabiee, Siavash Iravani
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 42, pp. 10072-10087
Closed Access | Times Cited: 12

Overview on biotics development
Anne-Emmanuelle Roux, Philippe Langella, Rebeca Martín
Current Opinion in Biotechnology (2024) Vol. 86, pp. 103073-103073
Open Access | Times Cited: 4

Microbiota transplantation and administration of live biotherapeutic products for the treatment of dysbiosis-associated diseases
Samantha Flores-Treviño, Paola Bocanegra‐Ibarias, Daniel Salas‐Treviño, et al.
Expert Opinion on Biological Therapy (2025)
Closed Access

Engineering advanced bacterial therapy for tumor and inflammatory diseases
Yuanyuan Chen, Qiuju Han
International Journal of Pharmaceutics (2025), pp. 125585-125585
Closed Access

Enhancing the persistence of engineered biotherapeutics in the gut: Adhesion, glycan metabolism, and environmental resistance
Yujin Lee, Hyun Gi Koh, Kyoung Heon Kim, et al.
Advanced Drug Delivery Reviews (2025), pp. 115591-115591
Closed Access

Live Probiotics-Loaded Delivery Systems for the Treatment of Infected Wounds
Oksana Gerulis, Karin Kogermann
NATO science for peace and security series. A, Chemistry and biology (2025), pp. 51-78
Closed Access

Translational strategies for oral delivery of faecal microbiota transplantation
Srinivas Kamath, Robert V. Bryant, Samuel P. Costello, et al.
Gut (2025), pp. gutjnl-335077
Closed Access

Maternal and infant microbiome: next-generation indicators and targets for intergenerational health and nutrition care
Shengtao Gao, Jinfeng Wang
Protein & Cell (2023) Vol. 14, Iss. 11, pp. 807-823
Open Access | Times Cited: 8

Expanding the genetic programmability of Lactiplantibacillus plantarum
Marc Blanch‐Asensio, Sourik Dey, Varun Sai Tadimarri, et al.
Microbial Biotechnology (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 8

The microbial-derived bile acid lithocholate and its epimers inhibit Clostridioides difficile growth and pathogenicity while sparing members of the gut microbiota
Samantha C. Kisthardt, Rajani Thanissery, Colleen M. Pike, et al.
Journal of Bacteriology (2023) Vol. 205, Iss. 9
Open Access | Times Cited: 8

Anti-Obesity Potential through Regulation of Carbohydrate Uptake and Gene Expression in Intestinal Epithelial Cells by the Probiotic Lactiplantibacillus plantarum MGEL20154 from Fermented Food
So Young Park, Jin Won Choi, Dong Nyoung Oh, et al.
Journal of Microbiology and Biotechnology (2023) Vol. 33, Iss. 5, pp. 621-633
Open Access | Times Cited: 7

Page 1 - Next Page

Scroll to top